Evome Medical Technologies Inc.

EVMT · V · Healthcare / Medical Devices

16.22CAD-0.18 (-1.13%)

Price History

Full chart

Market Stats

Previous Close16.40

Open16.20

Day Range16.18 – 16.22

52-Week Range0.005 – 0.005

Volume723

Market Cap413.52K

P/E (TTM)0.00

Forward P/E0.00

EPS-0.29

Dividend Yield0.00%

Beta1.31

50-Day Avg0.005

200-Day Avg0.005

About

Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Christopher Heath
Employees195
Headquarters49 Natcon Drive, Shirley, NY, United States, 11967, Canada
Websitehttps://www.evomemedical.com

Leadership

Mr. Christopher HeathInterim CEO & Director
Ms. Cherine Pottinger-HarrisPrincipal Accounting Officer & Interim Chief Financial Officer · b. 1981
Mr. William N. Garbarini Jr.Chief Operating Officer · b. 1970
Mr. William HauerVice President of Marketing & Sales
Ms. Heydi BensonDirector of Human Resources
Mr. Jethro Rothe-KushelVice President of Capital Markets & Financial Communications
Jeffrey ChuExecutive Officer

Financials

Income Statement

Currency: CAD	2019-11-30	2020-11-30	2021-11-30	2023-11-30
Total Revenue	352.13K	18.31M	18.31M	62.63M
Growth (%)	-	+5100.44%	0.00%	+242.00%
Cost of Revenue	17.76K	12.35M	12.35M	40.09M
Gross Profit	334.37K	5.96M	5.96M	22.53M
Gross Margin	94.96%	32.56%	32.56%	35.98%
Operating Expense	1.65M	10.41M	10.41M	28.66M
Operating Income	-1.31M	-4.45M	-4.45M	-6.13M
Operating Margin	-372.32%	-24.30%	-24.30%	-9.79%
EBITDA	-	-	-3.24M	-8.40M
EBITDA Margin	-	-	-17.71%	-13.41%
Net Income	-1.92M	-4.37M	-4.37M	-15.60M
Net Income Margin	-546.43%	-23.87%	-23.87%	-24.91%
Interest Expense	-	388.06K	388.06K	2.64M
Interest Expense % of Total Revenue	-	2.12%	2.12%	4.22%

Balance Sheet

Currency: CAD	2019-11-30	2020-11-30	2021-11-30	2023-11-30
Total Assets	9.73M	13.13M	42.68M	48.26M
Total Liabilities	232.48K	6.49M	29.53M	44.25M
Total Equity	9.50M	6.64M	13.15M	4.00M
Cash	8.35M	7.08M	8.06M	918.68K
Net Debt	-	-	-	15.86M

Cash Flow

Currency: CAD	2019-11-30	2020-11-30	2021-11-30	2022-11-30	2023-11-30
Operating Cash Flow	-197.61K	-3.70M	-3.70M	-	-918.91K
Financing Cash Flow	0	3.94M	3.94M	-	824.54K
Capital Expenditure	0	55.26K	55.26K	0	203.27K
Free Cash Flow	-197.61K	-3.76M	-3.76M	-	-1.12M
FCF to OCF	100.00%	101.49%	101.49%	-	122.12%

Earnings

Report Date	Oct 1, 2026
EPS Estimate	-
EPS Actual	-
Surprise	-
Timing	After-hours

Key Statistics & Ratios

Market Cap413.52K

Enterprise Value16.47M

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.01

Price / Book2.56

EPS-0.29

Book Value-0.042

Revenue (TTM)48.34M

Gross Profit (TTM)16.34M

EBITDA-3.65M

Profit Margin-48.68%

Operating Margin-4.55%

Return on Equity-294.80%

Return on Assets-6.67%

Shares Outstanding59.81M

Shares Float59.66M

Beta1.31

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20172×

0.01May 24, 20170.01Feb 10, 2017

20163×

0.10Nov 21, 20160.01Nov 14, 20160.01Aug 15, 2016

Stock Splits

Dec 15, 20200.737:1
Jan 27, 20161:8.871
Jul 14, 20151:1.765